Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients

Assiut University

Status: Not yet enrolling

Conditions: Critical Ill Patients

Treatments: Device: Hbg and RDW

Study type: Observational

Funder types: Other

Identifiers

NCT07057154

Rule of HBGA1C in critical ill

Details and patient eligibility

About

The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.

Full description

Primary (Main): determine the levels of the GHI And RDW In Critically Ill Patients at Critical and intermediate care units.

b. Secondary (Subsidiary): Evaluate the prognostic significance of these parameters on patient outcomes, such as overall survival, progression-free survival, response to treatment.

Enrollment: 97 estimated patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. patients admitted to Critical and Intermediate Care Units in Internal Medicine Department after history taking, examination and diagnosis
2. diabtic Patients 3-animic Patients

Exclusion criteria

• Patients under 18 years of age
• ICU stay < 24 h
• patients without HbA1c, FBG, or RDW data or anything's that's affect the HbA1c .